Product Information
PYRIDOSTIGMINE BR 60 MG TABLET is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.2487 per EA under NDC 62559047001. Its NADAC has been published 135 times since Mar 6, 2024.
FDA first approved this application on Oct 8, 2003. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
60 mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
62559047001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PYRIDOSTIGMINE BROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA040512FDA Approved
10/8/2003
TE Code
AB
On Market Since
1/16/2024
Pharmacological Classes
Price Statistics
The NADAC for PYRIDOSTIGMINE BR 60 MG TABLET has been published 135 times since Mar 6, 2024, and over the history we have for it it has risen 26.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2487 per EA |
|---|---|
| All-time high | $0.2753 (Dec 10, 2025) |
| All-time low | $0.1867 (Nov 20, 2024) |
| 52-week high | $0.2753 |
| 52-week low | $0.2487 |
| Median price | $0.2651 |
| Average price | $0.2576 |
| Largest weekly change | +30.5% (Dec 18, 2024) |
| Weeks tracked | 135 |
| Tracking since | Mar 6, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ANI Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Pyridostigmine Bromide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cholinesterase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PYRIDOSTIGMINE BR 60 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PYRIDOSTIGMINE BR 60 MG TABLET, manufactured by ANI Pharmaceuticals, Inc., is $0.2487 per EA (NDC 62559047001), effective Sep 30, 2026.
How has the price of PYRIDOSTIGMINE BR 60 MG TABLET changed over time?
Over the history we have for it, the NADAC for PYRIDOSTIGMINE BR 60 MG TABLET has risen 26.1%. It has been tracked across 135 weekly CMS publications since Mar 6, 2024.
What are the highest and lowest recorded NADAC prices for PYRIDOSTIGMINE BR 60 MG TABLET?
Since Mar 6, 2024, the NADAC for PYRIDOSTIGMINE BR 60 MG TABLET has ranged from a low of $0.1867 (Nov 20, 2024) to a high of $0.2753 (Dec 10, 2025), with a median of $0.2651 per EA.
Are there cheaper alternatives to PYRIDOSTIGMINE BR 60 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PYRIDOSTIGMINE BR 60 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures PYRIDOSTIGMINE BR 60 MG TABLET?
PYRIDOSTIGMINE BR 60 MG TABLET (NDC 62559047001) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.